Growth Metrics

Immuneering (IMRX) Payables: 2020-2023

Historic Payables for Immuneering (IMRX) over the last 4 years, with Dec 2023 value amounting to $2.1 million.

  • Immuneering's Payables rose 0.09% to $1.9 million in Q3 2024 from the same period last year, while for Sep 2024 it was $8.9 million, marking a year-over-year decrease of 14.88%. This contributed to the annual value of $2.1 million for FY2023, which is 33.06% down from last year.
  • As of FY2023, Immuneering's Payables stood at $2.1 million, which was down 33.06% from $3.2 million recorded in FY2022.
  • In the past 5 years, Immuneering's Payables ranged from a high of $3.2 million in FY2022 and a low of $1.4 million during FY2021.
  • For the 3-year period, Immuneering's Payables averaged around $2.2 million, with its median value being $2.1 million (2023).
  • Per our database at Business Quant, Immuneering's Payables surged by 126.24% in 2022 and then plummeted by 33.06% in 2023.
  • Immuneering's Payables (Yearly) stood at $1.5 million in 2020, then declined by 5.82% to $1.4 million in 2021, then skyrocketed by 126.24% to $3.2 million in 2022, then slumped by 33.06% to $2.1 million in 2023.